Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 20/100

Failure Rate

14.0%

6 terminated/withdrawn out of 43 trials

Success Rate

85.7%

-0.8% vs industry average

Late-Stage Pipeline

79%

34 trials in Phase 3/4

Results Transparency

86%

31 of 36 completed trials have results

Key Signals

31 with results

Enrollment Performance

Analytics

Phase 4

23(59.0%)

Phase 3

11(28.2%)

Phase 2

3(7.7%)

Phase 1

1(2.6%)

N/A

1(2.6%)

39Total

Phase 4(23)

Phase 3(11)

Phase 2(3)

Phase 1(1)

+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (43)

Showing 20 of 43 trials

NCT00539071Phase 4Completed

High Dose Risperidone Consta for Patients With Schizophrenia With Poor Response to Risperidone

Role: collaborator

NCT00799487Phase 4Completed

CONCERTA Lab School Study

Role: lead

NCT00206323Phase 3Completed

A Randomized, Placebo-controlled, Tourette Syndrome Study.

Role: collaborator

NCT00056498Phase 4Completed

Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine

Role: collaborator

NCT00745901Phase 4Completed

Study to Evaluate Cycle Control With Norgestimate/Ethinyl Estradiol and Drospirenone/Ethinyl Estradiol in Healthy Sexually Active Females

Role: lead

NCT00516269Phase 3Terminated

Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients

Role: collaborator

NCT00206336Phase 3Completed

An Open-label Study to Determine the Efficacy and Safety of Topiramate in the Treatment of Tourette Syndrome.

Role: collaborator

NCT00571688Phase 4Completed

Does Risperidone Consta Reduce Relapse and Rehospitalization in Bipolar Disorder?

Role: collaborator

NCT00549562Phase 3Completed

Study of Paliperidone ER in Adolescents and Young Adults With Autism

Role: collaborator

NCT01094886Phase 3Completed

Switching Drug Therapy for the Prevention of Blood Clot Formation From Enoxaparin to Rivaroxaban After Orthopedic Surgery for Either Total Hip or Total Knee Replacement

Role: lead

NCT01134731Phase 4Completed

Paliperidone and Lithium in the Treatment of Suicidality - Treatment Indication and Epigenetic Regulation

Role: collaborator

NCT00302458Phase 4Completed

A Study of Repeat Dosing of OROS® Methylphenidate Hydrochloride (CONCERTA®) and Immediate Release Methylphenidate Hydrochloride in Healthy Adults

Role: collaborator

NCT00352196Phase 4Completed

Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study

Role: collaborator

NCT00535145Phase 4Completed

Study to Measure the Safety of Paliperidone ER (Extended-release) in Patients With Liver Disease

Role: lead

NCT00771758Phase 3Completed

Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis

Role: lead

NCT00799409Phase 4Completed

Lab School Day Study for CONCERTA of Older Children With ADHD

Role: lead

NCT00632229Phase 2Completed

Double Blinded, Placebo-Controlled Trial of Paliperidone Addition in SRI-Resistant Obsessive-Compulsive Disorder

Role: collaborator

NCT01027897Phase 4Completed

Pharmacokinetic and Pharmacodynamic Evaluation of Doripenem in Critically Ill Trauma Patients

Role: collaborator

NCT00937040Phase 4Completed

Adult Study / OROS Methylphenidate Hydrochloride (HCL) (OROS MPH) in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

Role: lead

NCT01193166Phase 4Withdrawn

Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital

Role: lead